While definitive evidence is lacking, Ptp4a3 has been proposed to modulate multiple signaling pathways involving SRC [10], Rho GTPases [9], and PI3K-Akt [11] in various forms of cancer. This evidence concerns the gene PTP4A3 and cancer.